ABT-925: Clinical Trials

1 trial of ABT-925, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow ABT-925: new trials by email Literature Review of ABT-925 trials Research Report on ABT-925

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia
ABT-925, Placebo - Schizophrenia
Phase 2TerminatedAbbott1562006-12-012011-04-27

Conditions studied

Schizophrenia (1)

Sponsors

Abbott (1)

Countries

Argentina (1)  ·  Mexico (1)  ·  United States (1)

Top investigators

Beatrice Rendenbach-Mueller, PhD (1)

Results publications

PMID 21346607